NCT01163253 2017-06-26A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque PsoriasisPfizerPhase 3 Terminated2,867 enrolled 77 charts
NCT02201524 2016-10-05Study to Evaluate PF-04965842 in Patients With Moderate to Severe PsoriasisPfizerPhase 2 Terminated59 enrolled 18 charts